Sign In
Buy RMTI
$0.676
-0.0334 (-4.71%)
At Close: Jun 03, 2026
Rockwell Medical: Down But By No Means Out
12:48pm, Tuesday, 05'th Oct 2021
Management continues to invest behind its FPC drug platform.
Rockwell Medical, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
09:52am, Thursday, 09'th Sep 2021
WIXOM, Mich., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and
Rockwell Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
04:00pm, Thursday, 19'th Aug 2021
WIXOM, Mich., Aug. 19, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment
Rockwell Medical, Inc. (RMTI) CEO Russell Ellison on Q2 2021 Results - Earnings Call Transcript
12:40am, Tuesday, 17'th Aug 2021
Rockwell Medical, Inc. (RMTI) CEO Russell Ellison on Q2 2021 Results - Earnings Call Transcript
Rockwell Medical (RMTI) Reports Q2 Loss, Misses Revenue Estimates
07:48pm, Monday, 16'th Aug 2021
Rockwell Medical (RMTI) delivered earnings and revenue surprises of -12.50% and -11.64%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Rockwell Medical Q2 Earnings
04:45pm, Monday, 16'th Aug 2021
Shares of Rockwell Medical (NASDAQ:RMTI) fell 12.6% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 0.00% over the past year to ($0.09), w
Rockwell Medical, Inc. Provides Second Quarter 2021 Financial and Operational Update
04:09pm, Monday, 16'th Aug 2021
-Entered into exclusive license agreement with Drogsan Pharmaceuticals for the rights to commercialize Triferic® in Turkey-
Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
04:10pm, Monday, 09'th Aug 2021
Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WIXOM, Mich., June 28, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and
Rockwell Medical's (RMTI) CEO Russell Ellison on Q1 2021 Results - Earnings Call Transcript
06:30pm, Monday, 17'th May 2021
Rockwell Medical's (RMTI) CEO Russell Ellison on Q1 2021 Results - Earnings Call Transcript
Recap: Rockwell Medical Q1 Earnings
04:32pm, Monday, 17'th May 2021
Shares of Rockwell Medical (NASDAQ:RMTI) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 33.33% year over year to ($0.08), which beat
Rockwell Medical, Inc. Provides First Quarter 2021 Financial and Operational Update
04:05pm, Monday, 17'th May 2021
-Home Infusion FPC Program expected to initiate Phase 2 trial in second half of 2021-
Moving Average Crossover Alert: Rockwell Medical (RMTI)
07:31am, Monday, 26'th Apr 2021
Rockwell Medical (RMTI) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
WIXOM, Mich., April 22, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and
Rockwell Medical, Inc. (RMTI) CEO Russell Ellison on Q4 2020 Results - Earnings Call Transcript
10:09pm, Wednesday, 31'st Mar 2021
Rockwell Medical, Inc. (RMTI) CEO Russell Ellison on Q4 2020 Results - Earnings Call Transcript
